Admed Overseas Private Limited
About Admed Overseas Private Limited
Data last updated:
Admed Overseas Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 13 December 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2007PTC171419.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Core Medilab Private Limited. It is led by directors including Gyanesh Jeswal and Gourov.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at M – 27/2 Badli Industrial Estate Badli, New Delhi, Delhi, India – 110042.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Admed Overseas Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressM – 27/2 Badli Industrial Estate Badli, New Delhi, Delhi, India – 110042
- IndustryBusiness Outsourcing, Business & IT Consulting
To see the full contact details of Admed Overseas Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Admed Overseas Private Limited
FY 2025 filings availableAdmed Overseas Private Limited reported revenue of ₹8,100 (up 56% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 56% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Admed Overseas Private Limited, buy the company report.
Board of directors of Admed Overseas Private Limited
Admed Overseas has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gyanesh Jeswal Also directs: Warner India Lifesciences Limited, Prindey Travels Private Limited, Warner (India) Pharma Private Limited and 1 more | Director | 13 Dec 2007 | 18 Years 10 Months | Current |
| Gourov Also directs: Go4exports Private Limited | Director | 13 Jul 2023 | 3 Years 3 Months | Current |
| Vikas Goel Also directs: Victoris Print Solutions LLP, Knoll Pharmaceuticals Limited, Palohma Healthcare Private Limited and 3 more | Director | 13 Dec 2007 | 18 Years 10 Months | Current |
| Mayank Goel Also directs: Palohma Healthcare Private Limited, Warner (India) Pharma Private Limited, Gangesh Renewable Energy LLP and 5 more | Director | 28 Apr 2023 | 3 Years 6 Months | Current |
Peer comparison
Admed Overseas Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Polyplus Concentrates Private Limited | ₹8,735 (FY 2025) | Mumbai, Maharashtra, India | ||||
| Lau Kush Pharmacy Private Limited | ₹8,724 (FY 2024) | -98.0% | Kanpur, Uttar Pradesh, India | |||
| Medicode Pharmaceuticals Private Limited | ₹8,619 (FY 2021) | Hyderabad, Telangana, India | ||||
| Parenteral Surgicals Limited | ₹8,457 (FY 2021) | -100.0% | Mumbai, Maharashtra, India | |||
| Genx Pharma Private Limited | ₹8,328 (FY 2025) | Hyderabad, Telangana, India | ||||
| Admed Overseas Private Limitedthis company | ₹8,100 (FY 2025) | 56.0% | New Delhi, Delhi, India | |||
| Nivera Pharmaceuticals Private Limited | ₹8,031 (FY 2023) | -70.0% | Bangalore, Karnataka, India | |||
| Vincit Lifesciences Private Limited | ₹8,017 (FY 2020) | -97.0% | Surat, Gujarat, India | |||
| Lysten Global Pharmaceuticals Private Limited | ₹8,000 (FY 2023) | -97.0% | Kolhapur, Maharashtra, India | |||
| E L C Pharmaceuticals Private Limited | ₹8,000 (FY 2025) | -100.0% | New Delhi, Delhi, India | |||
| Pharmaceuticals and Chemicals Travancore Pvt Ltd | ₹7,723 (FY 2024) | -99.0% | Thiruvananthapuram, Kerala, India |
To see the full peer comparison of Admed Overseas Private Limited, buy the company report.
Auditor
Admed Overseas Private Limited is audited by NEHA PANDEY & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NEHA PANDEY & ASSOCIATES | FY 2023 | 031734N |
Shareholding
The shareholding of Admed Overseas Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Admed Overseas Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Admed Overseas Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Admed Overseas Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Admed Overseas Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Admed Overseas Private Limited has 6 board changes on record since 2007: 4 appointments and 2 cessations. The latest: . . Gourov ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Admed Overseas is an active private limited company based in New Delhi, Delhi, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 13 December 2007 (19+ years old) and is registered under CIN U24232DL2007PTC171419.
Admed Overseas has 4 current directors:
- Gyanesh Jeswal - Director
- Gourov - Director
- Vikas Goel - Director
- Mayank Goel - Director
The latest financial statements of Admed Overseas on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Admed Overseas is U24232DL2007PTC171419. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Admed Overseas was incorporated on 13 December 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Admed Overseas by revenue are Polyplus Concentrates Private Limited, Lau Kush Pharmacy Private Limited, Medicode Pharmaceuticals Private Limited, Parenteral Surgicals Limited, Genx Pharma Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
. Gourov ceased to be Additional Director on 29 Sep 2024. Mayank Goel ceased to be Additional Director on 29 Sep 2024. Gourov was appointed as Director on 13 Jul 2023. Admed Overseas has 6 board changes on record in total.
The registered office of Admed Overseas is at M – 272 Badli Industrial Estate Badli, New Delhi, Delhi, India – 110042.
Admed Overseas operates in the business outsourcing industry, in the business and IT consulting segment.
The compliance status of Admed Overseas is compliant as of 05 August 2026. The company is actively filing with the Registrar of Companies.
Yes. Admed Overseas was formerly known as Core Medilab Private Limited.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
